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Abstract: It has been demonstrated that the presence of cancer results in 
detectable changes to uninvolved tissues, collectively termed cancer field 
effects  (CFE).  In  this  study,  we  directly  assessed  the  ability  of  Raman 
microspectroscopy to detect CFE via in-vitro study of organotypic tissue 
rafts approximating human skin. Raman spectra were measured from both 
epidermis and dermis after transfer of the rafts to dishes containing adherent 
cultures of either normal human fibroblasts or fibrosarcoma (HT1080) cells. 
Principal components analyses allowed discrimination between the groups 
with 86% classification accuracy in the epidermis and 94% in the dermis. 
These results encourage further study to evaluate the Raman capacity for 
detecting  CFE  as  a  possible  tool  for  noninvasive  screening  for  tumor 
presence. 
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1. Introduction 
The idea that histologically normal tissue is biochemically altered by signals from adjacent 
tumor cells was hypothesized roughly 50 years ago [1]. Since that time, a number of reports 
have  validated  the  existence  of  several  signaling  mechanisms  and  pathways  involved  in 
response  to  cancer  [2].  These  responses  can  be  comprised  by  the  collective  phrases 
malignancy-associated changes (MAC) or cancer field effects (CFE): the concept that some of 
the  biological  variables  involved  in  neoplastic  lesion  formation  have  an  effect  on  nearby 
tissues.  This  phenomenon  could  potentially  enable  screening  and  diagnosis  of  cancer  via 
interrogation of readily accessible tissues, such as skin. The majority of CFE studies have 
relied on tissue processing or cellular isolation, however, neither of which fully account for 
the  intrinsic  behaviors  of  intact  tissue  nor  can  be  easily  translated  to  clinical  application. 
While CFE present a significant potential for novel cancer diagnostics, few studies to-date 
have demonstrated CFE detection methods that could be used in intact tissue. 
One method that has been clinically demonstrated for its ability to detect CFE in tissues is 
elastic light scattering. Backman et al. have performed considerable work using a variant of 
this phenomenon to show that tissues near a tumor are different from those further away from 
the tumor [3–5]. Because the method employed is keenly sensitive to changes in particle size 
within the field-of-view, they attribute the optical changes to microvasculature associated with 
tumorigenesis.  Based  on  these  detectable  changes,  they  have  demonstrated  diagnostic 
capabilities in healthy tissues as far as 30 cm away from the primary tumor [3], as well as the 
ability to detect cancer in an animal model well before it could be realized using conventional 
methods [4,5]. Yet elastic scattering is based on the morphology of the cellular and tissue 
environments,  features  that  change  in  response  to  biochemical  initiation.  By  utilizing  an 
optical technique that is capable of directly measuring the biochemistry within the cells and 
tissues, it may be possible to increase the sensitivity to CFE, both spatially and temporally. 
In recent years, there has been increasing interest in the use of Raman spectroscopy for 
tissue diagnostics. These studies have shown that features of the Raman spectrum can be 
related to molecular and structural changes associated with neoplastic transformation. Recent 
reports  have  demonstrated  the  successful  application  of  Raman  spectroscopy  for  disease 
characterization in vivo in vasculature [6], cervix [7], breast [8], and skin [9], among others. 
More  interesting,  however,  is  that  the  Raman  spectra  of  histologically  normal  tissues 
surrounding tumor have been shown to differ from the Raman spectra of tissues more distal to 
the tumor [10]. 
Combining the Backman group’s success using optical methods that probe particle size 
and morphology to detect CFE, the fact that these physical changes would be preceded by 
molecular  changes,  and  the  molecular  specificity  of  Raman  spectroscopy,  it  has  been 
hypothesized that these findings are supportive of Raman detection of CFE. In this work, we 
explore the effects of cancer presence on the Raman spectra of engineered tissue rafts. By 
culturing these organotypic rafts in proximity to-, but physically separated from cancerous 
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spectroscopy to detect CFE. 
2. Experimental 
The organotypic tissue culture raft models (“rafts”) used in this study were created according 
to published protocols [11]. In brief, these rafts consisted of a stromal equivalent containing a 
collagen-matrix  with  embedded  fibroblasts,  over  which  an  epidermis  of  differentiated 
keratinocytes was grown. The rafts were incubated on a wire mesh suspended approximately 
3 mm above the bottom of a 60 mm culture dish. Culture media was added (~8 mL) such that 
it reached the wire mesh but no part of the raft was submerged. Rafts were differentiated 
under normal conditions for 8 days (as per protocol), after which the mesh grids containing 
the  rafts  were  transferred  to  60  mm  dishes  containing  adherent  cultures  of  either  normal 
fibroblasts (derived from human skin) or fibrosarcoma (HT1080) cells. At the time of transfer, 
both the fibroblast and HT1080 cultures were ~70% confluent. Media was added, as before, 
only  to  the  level  of  the  mesh.  For  clarity,  those  rafts  transferred  to  dishes  containing 
fibroblasts are termed “naïve” throughout this manuscript, while those co-cultured with the 
HT1080 cells are termed “tumor-associated.” To ensure isolation between the rafts and the 
plated  cells,  the  rafts  were  transferred  to  new  dishes  with  adherent  cultures  of  the  same 
respective cell types (~70% confluence) at each change of media, every 2 days. Adhesion of 
the cells to the dish was confirmed by inverted phase microscopy of each dish prior to any 
spectral measurements, thus ensuring that the cultured cells did not infiltrate the rafts. 
Rafts  were  created  in  6  separate  dishes,  equally  divided  between  naïve  and  tumor-
associated,  with  2  rafts  per  dish.  The  rafts  were  created  such  that  the  epidermis  did  not 
completely  overlap  the  dermis,  thereby  allowing  spectral  measurement  of  the  two  strata 
without  need  for  a  confocal  setup  and  increased  measurement  times.  Three  spectral 
measurements  were  obtained  from  both  dermis  and  epidermis  of  each  raft,  at  multiple 
positions  around  the  raft.  Thus,  each  population  (naïve,  tumor-associated)  yielded  18 
epidermal  spectra  and  18  dermal  spectra  on  each  day  of  measurement.  The  spectral 
measurements  were  performed  before  the  rafts  were  associated  with  the  plated  cells,  and 
every 1-3 days until analysis of that day’s raft spectra revealed a statistical change between 
the naïve and tumor-associated populations, after which no subsequent spectra were obtained. 
Spectra  were  also  measured  of  the  isolated  cells  used  in  the  adherent  cultures  (normal 
fibroblasts  and  HT-1080).  These  cells  were  smeared  onto  a  fused  quartz  slide  and  five 
measurements of each cell type were obtained from various positions around the smear. 
Raman  measurements  were  obtained  using  a  Raman  microspectrometer  (RM1000, 
Renishaw  PLC,  Wotton-under-Edge,  UK).  In  brief,  this  system  is  based  on  an  upright 
microscope frame with attached spectrometer, and a 785 nm laser providing approximately 40 
mW illumination power to the sample, through a 20 × , 0.4 NA objective (model 566026, 
Leica  Microsystems,  Wetlzar,  Germany);  the  system  was  operated  in  non-confocal  mode. 
Spectral measurements were obtained using 30-60 sec. integration, from 600 to 1800 cm
−1, 
binned to 3 cm
−1. For each experiment, the instrument was calibrated for spectral dispersion 
(Ne:Ar  lamp),  Raman  shift  (acetaminophen),  and  spectral  response  (NIST  2241  glass). 
Instrument  background  signal  was  subtracted  from  each  tissue  spectrum.  Fluorescence 
background was subtracted via the modified polynomial fitting method [12], using the full 
wavenumber range and 5th order fit. High order (shot) noise was removed using a 2nd order 
Savitzky-Golay smoothing filter. All processed spectra were normalized to respective mean 
intensity and mean centered prior to statistical comparison. 
The spectral data set was analyzed each measurement day using principal components 
analysis (PCA) in the Matlab (Mathworks Inc., Natick, MA) programming environment (the 
epidermal and dermal measurements were evaluated separately). That day’s full spectral data 
set was input with each wavenumber intensity representing a separate predictor variable, using 
leave-one-out cross-validation. PCA scores were used to assess diagnostic accuracy of the 
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tumor-associated  raft  populations  with  a  minimum  of  classification  error.  Sensitivity  and 
specificity were calculated using this class separator. Because there were only two classes 
evaluated,  it  is  important  to  note  that  these  sensitivity  and  specificity  values  are 
interchangeable. Overall classification accuracy was also calculated as the total number of 
correctly classified measurements per total measurements each day. 
3. Results 
Statistical analysis of the Raman spectra produced no significant discrimination between the 
populations’  epidermal  or  dermal  measurements  until  8  days  after  co-culture  with  the 
respective  plated  cells.  Figure  1(A)  shows  the  mean  Raman  spectra  of  both  epidermal 
populations  after  8  days  of  co-culture.  Qualitatively,  there  are  slight  spectral  differences 
between the two populations that are more readily visualized in Fig. 1(C), which shows the 
mean difference spectrum (tumor-associated minus naïve). The most apparent difference is 
seen in amino acid bands near 855 cm
−1 (tyrosine, proline) and 1004 cm
−1 (phenylalanine). 
The 1004 cm
−1 band has also been attributed to the C–C vibration of keratin [13]. There is 
also some change in the amide III, protein, and lipid band region between approximately 1250 
and 1340 cm
−1. 
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Fig. 1. Mean Raman spectra of the raft layers after co-culture with the adherent cell cultures for 
both the (A) epidermis and (B) dermis. Difference spectra (tumor-associated minus naïve; +/− 
standard deviation) are also shown to clarify Raman spectral changes in the (C) epidermis and 
(D) dermis. 
Figure 1(B) shows the mean Raman spectra measured on the dermis that protruded slightly 
from the perimeter of the epidermis. These spectra are qualitatively more dissimilar between 
the naïve and tumor-associated populations than in the epidermis, the regions of which are 
more readily seen in the difference spectrum in Fig. 1(D). The dermal difference spectrum 
identifies  many  of  the  same  general  Raman  bands  shown  in  the  epidermis,  with  slight 
variation. The dermal spectra are most different in the 858 cm
−1 shoulder of the 855 cm
−1 
tyrosine/proline  peak,  and  in  the  1018  cm
−1  neck  region  between  the  1004  cm
−1 
phenylalanine/keratin  peak  and  the  1040  cm
−1  peak  attributed  to  both  proline  [14]  and 
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dermal spectra also show more distinct disparity in the CH2 and CH3 deformations revealed in 
the 1420 cm
−1 region. 
Plotting of the principal component (PC) scores reveals a clear separation of the two raft 
populations in both the epidermal and dermal spectra. As seen in Fig. 2(A), a decision line 
separating the epidermal measurements of the two populations accurately discriminates 17/18 
tumor-associated raft spectra, and 14/18 naïve spectra, for a sensitivity and specificity of 94% 
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Fig.  2.  Principal  component  analysis  of  the  Raman  spectral  measurements  of  the  two  raft 
populations (red triangles = naïve, green asterisks = tumor-associated) shows overall separation 
in  both  (A)  epidermis  and  (B)  dermis  using  just  two  component  scores  for  each  stratum. 
Component loadings for (C) epidermis and (D) dermis reveal similar band positions to mean 
difference spectra. 
and 78%, respectively, and an overall classification accuracy of 86% (31/36). Figure 2(B) 
shows the application of a decision line to the PC scores of the dermal measurements, which 
yield a higher discriminant accuracy of 18/18 tumor-associated raft spectra and 16/18 naïve 
raft spectra, for a sensitivity and specificity of 100% and 89%, respectively, and an overall 
classification accuracy of 94% (34/36). 
The loading plots of the PCA, seen in Fig. 2(C) (epidermis) and 2D (dermis) reveal that 
the Raman band regions responsible for the PC score discrimination are largely the same as 
those regions identified in the difference spectra. In addition, the epidermis PCs load on the 
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−1 peak of proline, valine, and 
glycogen, the 1095 cm
−1 peak of the DNA phospholipids backbone, and the CH2 bending 
mode of proteins and lipids near 1448 cm
−1. The dermal spectral loadings are nearly identical 
to the difference spectra, adding the strong amide I band near 1660 cm
−1. 
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Fig. 3. (A) Mean Raman spectra of the cell lines used to induce changes in tissue rafts, and (B) 
their difference spectrum with the mean epidermal and dermal raft difference spectra. 
The mean Raman spectra of both the normal fibroblasts and the HT1080 fibrosarcoma 
cells are shown in Fig. 3(A). The difference spectrum of these cells, shown in Fig. 3(B), 
shows much higher relative intensities and dissimilar band locations as compared to the mean 
difference spectra from the raft measurements. PCA of the cellular spectra allowed complete 
discrimination between the cell lines using the first two PCs. The peak locations exhibiting 
high loadings are marked on the spectra. These include the nucleotide peak at 783 cm
−1, the 
tyrosine peaks at 827 and 851 cm
−1 (also representing DNA backbone and proline), the wide 
shoulder band of the protein amide III band near 1257 cm
−1, and the CH2 peak of lipids and 
proteins centered near 1445 cm
−1. Applying this PCA model to the raft spectra yielded no 
discriminant ability (~50% error) for either the epidermal or dermal measurements, suggesting 
that  the  cells  themselves  were  not  responsible  for  the  discrimination  between  the  raft 
populations. 
4. Discussion 
Optical methods such as Raman spectroscopy have an ever-increasing body of support in 
scientific literature for their abilities to successfully discriminate tissue pathology. While the 
noninvasive  nature  and  capacity  for  automated  diagnosis  based  on  biochemistry  is  the 
hallmark advantage of optical techniques, there remains the physical mandate that light must 
be transmitted to- and received from the tissue of interest. Thus the majority of reports on so-
called  “optical  biopsy”  target  readily  accessible  organs  and  tissues  such  as  skin, 
gastrointestinal and gynecologic tracts. But for those other tissues, more technical complexity 
in  light  delivery/collection  is  necessary,  and  oftentimes  requires  at  least  some  minimal 
invasion. Thus, the motivation behind this work: if a tumor causes changes to surrounding 
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detected by performing optical biopsy of an accessible tissue region. Such capabilities have 
been indirectly indicated in previous clinical Raman studies, including those of the author and 
former colleagues [9,10]. In this report, we confirm the Raman capacity to detect changes in 
normal tissues caused by adjacent tumor. 
The raft model was chosen for this study to maximize control over unassociated variables. 
The  clinical  Raman  studies  included  in  the  paper  by  Keller  et  al.  provide  circumstantial 
evidence of Raman detection of CFE, but the referenced studies were not controlled for this 
purpose  and,  as  such,  could  not  accurately  posit  the  correlation  between  Raman  spectral 
changes and CFE. This same work also includes a comparison of Raman spectra obtained 
from raft cultures created with and without cancerous cells in the epidermis and dermis. While 
no discrimination was performed, their findings that the spectral changes are more intense in 
the dermis than in the epidermis mirror the findings presented here. 
While the experimental model used in this study does allow validation of the effect of 
cancerous cells on non-cancerous tissues, the reliance on medium as a conductor between the 
adherent cell monolayers and the tissue rafts is not ideal for understanding progression of CFE 
in-vivo. Particularly, the volume of the medium used in the model and its rate of exchange 
may effect the time at which the spectral changes necessary for discrimination could arise. 
Furthermore, the use of medium as conductor minimizes the characterization of cell-to-cell 
transmittance of CFE, as would occur in solid tumors and surrounding tissues. It is important 
to note that these abovementioned reasons minimize the temporal import of our findings, in 
that slight changes of our model may increase or decrease the number of days at which the 
Raman  spectra  can  reliably  register  a  change.  Regardless  of  the  model’s  shortcomings, 
however, it does allow proof-of-concept of the Raman detection of CFE. 
In order to avoid any chance raft-to-raft spectral differences from obscuring our intended 
experimental result, we took multiple steps in the experiment design and analysis. First, we 
separated the rafts into multiple dishes, thus any unforeseen changes in one dish would not 
contaminate the entire population spectral data set. Second, we placed two rafts in each dish, 
thus any anomalies in one raft could be verified against another within the same dish. Third, 
and perhaps most important, we attempted to discriminate the raft populations’ spectra not 
only after co-culture with the plated cells but also before the rafts were co-cultured with the 
plated cells, and could not produce a significant discriminant result until the stated 8 days of 
co-culture,  even  using  less  conservative  statistical  tools  such  as  partial  least  squares 
discriminant  analysis  (PLSDA)  or  linear  discriminant  analysis  (LDA)  of  the  PCA  scores. 
Based on these safeguards,  we can reliably assert that the changes seen between the two 
populations are the result of association with cancerous cells. 
The spectral changes that resulted in discrimination between the two populations did not 
present gradually, as might be expected. Rather, the spectra did not produce any significant 
discrimination (e.g. classification error ~50%) over the first seven days after co-culture with 
the plated cells, then showed a clear distinction on the 8th day. This is most likely due to 
detection limits of the Raman technique, whereby the slight changes over the first 7 days did 
not produce the magnitude of biochemical change necessary to overcome inherent noise of the 
system  and  sample.  Similarly,  measurement  of  the  media  from  the  raft  dishes  produced 
relatively  low  Raman  signal,  and  the  spectra  did  not  allow  discrimination  between  the 
populations. Continuing experiments in the raft models and in animal or human studies will 
evaluate the progression of these changes temporally and spatially, to further elucidate CFE 
distribution. 
Many of the spectral features that are identified as diagnostically relevant are similar to 
those identified in many Raman studies of various pathological tissues, such as the amide 
bands, prominent CH2 peak, amino acids, and bases and backbone of nucleic acids. This is 
obvious  given  that  these  elements  largely  form  the  basis  of  biological  materials.  Yet  the 
Raman  band  near  1040  cm
−1  that  presents  in  the  dermal  measurements  is  not  typically 
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cm
−1 is attributed to fused silica from the instrument optics, but because this study accounted 
for background signal it is unlikely to be the source of the band. Frank et al. found this feature 
in ex vivo  measurements of  breast tissue and attributed it to proline [14]. However, their 
samples were fixed in formalin prior to measurement, which has previously been shown to 
produce a tissue peak near 1040 cm
−1 related to the formalin [16]. An in vivo skin Raman 
study has identified this peak to be a result of albumin oxidation, and tested this attribution by 
measuring purified cysteic acid, known to cause delinking of the albumin disulfide bonds 
[15]. Nearby peaks also appear in published spectra of cervix, where a band at 1048 cm
−1 is 
attributed to glycogen [10], and in skin, where a peak at 1032 cm
−1 is identified as C–C 
stretching modes of keratin [13]. It remains to be determined whether this Raman spectral 
feature  is  related  to  the  CFE,  or  whether  it  is  an  artifact  in  cultured  tissues  due  to  the 
fortification of cell and tissue culture media with bovine albumin. This will most likely be 
answered as these studies progress from the Petri dish into animal or clinical analyses. 
Based on the changes described previously using various raft models [10,11] as well as the 
results of this study, the Raman spectral changes can be attributed to CFE with more certainty. 
Further study is obviously warranted to broaden characterization of these changes, including 
their reversibility, the manner of their spread within and beyond tissues, the distance at which 
these changes can be detected, and whether the CFE are unique to the tumor type. Beyond this 
basic exploration, study in animal and/or clinical studies can further elucidate the nature of 
CFE  detectability  in  multi-tissue  and  trans-organ  environs,  including  the  effects  of 
hemodynamics and lymphatic circulation. Exploitation of this effect could potentially allow 
the  use  of  Raman  spectroscopy  for  rapid  screening  and  diagnosis  of  internal  tumors  by 
measuring readily accessible anatomy. 
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